简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 2.70% in Intraday Trade, Latest NAV at HKD 3.872
Tags:
07522.HK
ETF
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
2026-07-24
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rose 4.01% in Morning Trade, Turnover at HKD 1.8361 Million
Tags:
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ETF
2026-07-17
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Falls 1.62% in Afternoon Trade, AUM at HKD 191.00 Million
Tags:
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ETF
2026-07-09
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 5.85% in Afternoon Trade, Latest NAV at HKD 3.637
Tags:
ETF
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
2026-06-26
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product(07522.HK) Rises 1.58% Intraday at an Average Price of HK$3.872
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-06-11
Featured News
Finance
Extreme Vision (06636.HK): Interim Revenue Forecast to Surge 160%–180%, Turnaround in Adjusted Net Profit
Finance
China Glass Holdings(03300.HK): Expected to Swing to Profit in Interim Period, Net Profit Forecasted at RMB 35 Million to RMB 65 Million
Finance
Anhui Expressway(00995.HK): Plans to Issue Corporate Bonds of Up to RMB 800 Million
Finance
HBM Holdings(02142.HK): Strategic Cooperation Established with Sinopharm Group
Finance
Transport International(00062.HK): Change of Company Secretary and Authorised Representative
Research
Autonomous Driving Concept Stocks Watch | XPENG-W(09868.HK) Edges Lower in Afternoon Session, Five Brand-New Vehicle Models to Be Launched in H2 2026
Finance
JIANGXI BIOLOGY(06915.HK): Veterinary Tetanus Antitoxin Production Line Officially Put into Operation
Finance
Anker Innovations (00668.HK): H-shares Included in Stock Connect Eligible Securities List
Finance
IMPACT Therapeutics(07630.HK): IMP3201 Nominated as Preclinical Candidate Compound, a Dual-Loaded ADC Targeting CEACAM5
Finance
JIANGXI BIOLOGY(06915.HK): Stabilisation Period Concludes, Over-Allotment Option Lapses
Scan QR Code
Download App